| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Berardo Sarubbi | Q50674323 |
| P2093 | author name string | A Iacono | |
| V Ducceschi | |||
| L Santangelo | |||
| B Russo | |||
| G Di Micco | |||
| P2860 | cites work | Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing | Q28272594 |
| Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators | Q28323471 | ||
| Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug | Q28336357 | ||
| Oscillations of intracellular Ca2+ in mammalian cardiac muscle. | Q34272765 | ||
| Classifying antiarrhythmic actions: by facts or speculation | Q34292204 | ||
| Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction | Q34415281 | ||
| How to prescribe and manage antiarrhythmic drug therapy | Q35654171 | ||
| Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial | Q37326986 | ||
| The role of magnesium in cardiac arrhythmias | Q37921857 | ||
| Magnesium ions in cardiac function. Regulator of ion channels and second messengers | Q38200000 | ||
| Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction | Q38701805 | ||
| Magnesium deficiency in coronary artery disease and cardiac arrhythmias. | Q38713046 | ||
| Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium | Q39280876 | ||
| Potassium and experimental coronary occlusion | Q40036429 | ||
| Drugs with a class III antiarrhythmic action | Q40252552 | ||
| Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos | Q40388359 | ||
| Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia | Q40630757 | ||
| Ionic basis of ischaemic cardiac injury: insights from cellular studies | Q40668896 | ||
| Stress-induced arrhythmic disease of the heart--Part I. | Q40704791 | ||
| Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis | Q40716733 | ||
| Cardiac receptor activation and arrhythmogenesis. | Q40773416 | ||
| Torsade de pointes and magnesium deficiency | Q70046751 | ||
| Spontaneous ventricular tachycardia associated with isolated right ventricular infarction, one day after right coronary artery occlusion in the dog: studies on the site of origin and mechanism | Q70046814 | ||
| Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing | Q70058535 | ||
| Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine one-day-old myocardial infarction. Evidence for focal and reentrant mechanisms | Q70396638 | ||
| Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction | Q70718093 | ||
| Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? | Q72091615 | ||
| QT dispersion does not predict early ventricular fibrillation after acute myocardial infarction | Q72120076 | ||
| QT dispersion and mortality after myocardial infarction | Q72152633 | ||
| Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction | Q72220324 | ||
| Potassium channel openers are likely to be proarrhythmic in the diseased human heart | Q72710671 | ||
| Antiarrhythmic effects of nicorandil on canine cardiac Purkinje fibers | Q72751087 | ||
| Excitatory factors in ventricular tachycardia resulting from myocardial ischemia; potassium a major excitant | Q73417779 | ||
| Cellular electrophysiological properties in myocardial infarction | Q40773426 | ||
| Drug therapy for torsade de pointes | Q40794997 | ||
| Magnesium and the heart: antiarrhythmic therapy with magnesium | Q40795208 | ||
| Mechanisms and control of repolarization | Q40807704 | ||
| Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization | Q40807708 | ||
| New class III antiarrhythmic drugs | Q40807719 | ||
| The origin of ventricular arrhythmias 24 hours following experimental anterior septal coronary artery occlusion | Q41052771 | ||
| Fluctuations in membrane current driven by intracellular calcium in cardiac Purkinje fibers | Q41117321 | ||
| Antiarrhythmic actions of the ATP-regulated K+ current activated by pinacidil | Q41180927 | ||
| A model for early afterdepolarizations: induction with the Ca2+ channel agonist Bay K 8644. | Q41251946 | ||
| Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs | Q41437028 | ||
| Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle | Q41908559 | ||
| Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus | Q42160833 | ||
| Termination of ouabain-induced ventricular tachycardia by flunarizine in conscious dogs | Q42198898 | ||
| Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits | Q42280704 | ||
| Role of cardiac ATP-regulated potassium channels in differential responses of endocardial and epicardial cells to ischemia | Q42628313 | ||
| Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy | Q43468347 | ||
| Transient inward current in guinea-pig atrial myocytes reflects a change of sodium-calcium exchange current. | Q43560431 | ||
| Influence of KATP channel modulation on net potassium efflux from ischaemic mammalian cardiac tissue | Q43984379 | ||
| Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation | Q44628539 | ||
| Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells | Q44943268 | ||
| Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea | Q46238139 | ||
| The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium | Q46322717 | ||
| The effect of inhibition of mitochondrial energy metabolism on the transient inward current of isolated guinea-pig ventricular myocytes | Q46482647 | ||
| A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function | Q46536654 | ||
| Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts | Q46637834 | ||
| Role of L-type calcium channel window current in generating current-induced early afterdepolarizations | Q46667979 | ||
| Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) | Q51689005 | ||
| The role of potassium and sodium-calcium exchange currents in the action potential durations of normal Purkinje fibres and Purkinje fibres surviving infarction. | Q51754198 | ||
| Treatment of torsade de pointes with magnesium sulfate. | Q51775622 | ||
| Triggered ventricular rhythms in 1-day-old myocardial infarction in the dog. | Q52281474 | ||
| Ionic basis of transient inward current induced by strophanthidin in cardiac Purkinje fibres. | Q52705213 | ||
| Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. | Q53722803 | ||
| Spontaneous and Induced Cardiac Arrhythmias in Subendocardial Purkinje Fibers Surviving Extensive Myocardial Infarction in Dogs | Q53881927 | ||
| Glibenclamide, but not class III drugs, prevents ischaemic shortening of the refractory period in guinea-pig hearts. | Q54043936 | ||
| Direct measurement of L-type Ca2+ window current in heart cells | Q54066981 | ||
| Electrical properties of canine subendocardial Purkinje fibers surviving in 1-day-old experimental myocardial infarction. | Q54334128 | ||
| Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease | Q57789319 | ||
| Ventricular refractoriness during acute myocardial ischaemia and its relationship to ventricular fibrillation | Q67339700 | ||
| Reperfusion arrhythmias in isolated perfused pig hearts. Inhomogeneities in extracellular potassium, ST and TQ potentials, and transmembrane action potentials | Q67552798 | ||
| The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology | Q67700855 | ||
| Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization | Q68084281 | ||
| Magnitude and time course of extracellular potassium inhomogeneities during acute ischemia in pigs. Effect of verapamil | Q68189735 | ||
| Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation | Q68409716 | ||
| Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers | Q68797503 | ||
| Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers | Q69355482 | ||
| Survival of Subendocardial Purkinje Fibers after Extensive Myocardial Infarction in Dogs | Q69608502 | ||
| Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction | Q69624483 | ||
| Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: significance for ischemic and reperfusion arrhythmias | Q69833282 | ||
| Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium | Q69947970 | ||
| Extracellular potassium ion dynamics and ventricular arrhythmias in the canine heart | Q69965406 | ||
| Ventricular conduction delay and arrhythmias during regional hyperkalemia in the dog. Electrical and myocardial ion alterations | Q70003460 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 325-331 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Ionic mechanisms of ischemia-related ventricular arrhythmias | |
| P478 | volume | 19 |
| Q34623717 | Aldosterone receptor blockade in the management of heart failure |
| Q51653134 | Effects of chronic hypoxia on inward rectifier K(+) current ( I(K1)) in ventricular myocytes of crucian carp (Carassius carassius) heart. |
| Q36769839 | Effects of nerve growth factor on the action potential duration and repolarizing currents in a rabbit model of myocardial infarction |
| Q38678276 | Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a 3D microtissue environment |
| Q45711402 | Incessant ventricular tachycardia as a manifestation of myocardial ischemia |
| Q36359091 | Laser-Etched Designs for Molding Hydrogel-Based Engineered Tissues |
| Q34821518 | Mechanisms underlying the development of atrial arrhythmias in heart failure |
| Q48648327 | The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs |
| Q46610835 | The electrical and mechanical response of adult guinea pig and rat ventricular myocytes to omega3 polyunsaturated fatty acids |
| Q36915712 | Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. |
Search more.